Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Record numbers expected at CPHI & PMEC China 2024 as Asian markets boom

Friday, June 14, 2024

CPHI PMEC China June st returns to the Shanghai New International Expo Center amid soaring demand across the pharmaceutical supply chain in Asia China already the primary source of pharmaceutical ingredients and starting materials globally

Ethypharm Expands Its Mesalazine (Etiasa®) Portfolio in China

Friday, June 14, 2024

Ethypharm is pleased to announce the acquisition of a suppository form of Mesalazine by its Chinese affiliate Shanghai Ethypharm Pharmaceuticals Ltd from the Chinese Company Jiangsu Anbison Pharmaceutical Leader in essential medicines for central ner... Collaborates with Hypertrophic Cardiomyopathy Association to Improve Care for Hypertrophic Cardiomyopathy Patients

Friday, June 14, 2024

Vizai the leader in AIpowered disease detection and intelligent care coordination today announced a collaboration with the Hypertrophic Cardiomyopathy Association the preeminent organization

SKAN Research Trust and Quadram Institute Bioscience to Develop Novel Microbial Therapies

Friday, June 14, 2024

SKAN Research Trust promoted by Indian entrepreneur Mr Ashok Soota and UKbased Quadram Institute Bioscience today announced that they will apply the cutting

Sirnaomics Demonstrates Strong Antitumor Activity of Its Novel Oligonucleotide-ChemoDrug Conjugate in Journal of Oncology Research and Therapy

Friday, June 14, 2024

Sirnaomics Ltd a leading biopharmaceutical company in discovery and development of RNAi therapeutics today announced that the Group

GSK Enters Into A Multi-Year Data Licence Agreement With Ochre Bio To Further Investigate The Drivers Of Liver Disease

Thursday, June 13, 2024

Ochre Bio a pioneer in chronic liver disease medicine development has today announced the start of a multiyear data licence agreement with GSK The partnership will provide GSK with access to Ochre Bios

OBI Pharma Announces Phase 1/2 Study Initiation for OBI-992, a TROP2-Targeted Antibody-Drug Conjugate (ADC) for Cancer Therapy

Thursday, June 13, 2024

OBI Pharma a clinicalstage oncology company today announced the initiation of a Phase clinical trial of OBI an antibodydrug conjugate targeting TROP

Sibylla Biotech and MD Anderson Announce Strategic Collaboration to Discover and Develop Small-Molecule Protein Degraders

Thursday, June 13, 2024

Sibylla Biotech and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration agreement to discover and develop novel smallmolecule cancer therapies

Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan

Thursday, June 13, 2024

Belite Bio Inc a clinicalstage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs

Bespak Reaches Key Milestone in the Expansion of Its Manufacturing Capacity, With Further Expansion Plans Underway to Meet Global Customer Demand for Climate Friendly Inhalers

Wednesday, June 12, 2024

Bespak a leading contract development and manufacturing organisation focused on orally inhaled

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Advanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024